Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2025-12-25 @ 12:53 AM
NCT ID:
NCT00806767
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of a hematological malignancy
* Candidate for an allogeneic hematopoietic stem cell transplantation
* Available HLA-identical related donor
PATIENT CHARACTERISTICS:
* WHO performance status (PS) 0-1 OR Karnofsky PS 70-100%
* Life expectancy \> 6 months
* LVEF ≥ 40%
* DLCO ≥ 50%
* Creatinine clearance ≥ 30 mL/min
* Transaminases and/or bilirubin ≤ 2 times upper limit of normal (ULN)
* No other cancer within the past 5 years, except for basal cell carcinoma of the skin or carcinoma in situ of the cervix
* No human T-cell leukemia virus type 1 positivity
* No HIV positivity
* No uncontrolled bacterial, viral, or fungal infection
* No contraindications to the study drugs
* No concurrent serious and uncontrolled disease
PRIOR CONCURRENT THERAPY:
* At least 1 month since prior participation in a clinical trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
56 Years
Maximum Age:
74 Years
Study:
NCT00806767
Study Brief:
Protocol Section:
NCT00806767